BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 32326212)

  • 1. Matriptase Cleaves EpCAM and TROP2 in Keratinocytes, Destabilizing Both Proteins and Associated Claudins.
    Wu CJ; Lu M; Feng X; Nakato G; Udey MC
    Cells; 2020 Apr; 9(4):. PubMed ID: 32326212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Matriptase-mediated cleavage of EpCAM destabilizes claudins and dysregulates intestinal epithelial homeostasis.
    Wu CJ; Feng X; Lu M; Morimura S; Udey MC
    J Clin Invest; 2017 Feb; 127(2):623-634. PubMed ID: 28094766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EPCAM and TROP2 share a role in claudin stabilization and development of intestinal and extraintestinal epithelia in mice.
    Szabo R; Ward JM; Artunc F; Bugge TH
    Biol Open; 2022 Jul; 11(7):. PubMed ID: 35730316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epithelial cell adhesion molecule (EpCAM) regulates claudin dynamics and tight junctions.
    Wu CJ; Mannan P; Lu M; Udey MC
    J Biol Chem; 2013 Apr; 288(17):12253-68. PubMed ID: 23486470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeted deletion of HAI-1 increases prostasin proteolysis but decreases matriptase proteolysis in human keratinocytes.
    Lu DD; Gu Y; Li SA; Barndt RJ; Huang SM; Wang JK; Su HC; Johnson MD; Lin CY
    Hum Cell; 2021 May; 34(3):771-784. PubMed ID: 33486722
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trop2 Forms a Stable Dimer with Significant Structural Differences within the Membrane-Distal Region as Compared to EpCAM.
    Pavšič M
    Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N-glycosylation status of Trop2 impacts its surface density, interaction with claudin-7 and exosomal release.
    Kamble PR; Patkar SR; Breed AA; Pathak BR
    Arch Biochem Biophys; 2021 Dec; 714():109084. PubMed ID: 34774484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteolytic cleavage of Trop2 at Arg87 is mediated by matriptase and regulated by Val194.
    Kamble PR; Rane S; Breed AA; Joseph S; Mahale SD; Pathak BR
    FEBS Lett; 2020 Oct; 594(19):3156-3169. PubMed ID: 32761920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Matriptase drives early-onset intestinal failure in a mouse model of congenital tufting enteropathy.
    Szabo R; Callies LK; Bugge TH
    Development; 2019 Nov; 146(22):. PubMed ID: 31628112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early-onset tufting enteropathy in HAI-2-deficient mice is independent of matriptase-mediated cleavage of EpCAM.
    Szabo R; Kawaguchi M; Kataoka H; Bugge TH
    Development; 2023 Sep; 150(17):. PubMed ID: 37539662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EpCAM contributes to formation of functional tight junction in the intestinal epithelium by recruiting claudin proteins.
    Lei Z; Maeda T; Tamura A; Nakamura T; Yamazaki Y; Shiratori H; Yashiro K; Tsukita S; Hamada H
    Dev Biol; 2012 Nov; 371(2):136-45. PubMed ID: 22819673
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatocyte growth factor activator inhibitor-2 stabilizes Epcam and maintains epithelial organization in the mouse intestine.
    Kawaguchi M; Yamamoto K; Takeda N; Fukushima T; Yamashita F; Sato K; Kitamura K; Hippo Y; Janetka JW; Kataoka H
    Commun Biol; 2019; 2():11. PubMed ID: 30623107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amelioration of Congenital Tufting Enteropathy in EpCAM (TROP1)-Deficient Mice via Heterotopic Expression of TROP2 in Intestinal Epithelial Cells.
    Nakato G; Morimura S; Lu M; Feng X; Wu C; Udey MC
    Cells; 2020 Aug; 9(8):. PubMed ID: 32781650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Claudin-7 regulates EpCAM-mediated functions in tumor progression.
    Nübel T; Preobraschenski J; Tuncay H; Weiss T; Kuhn S; Ladwein M; Langbein L; Zöller M
    Mol Cancer Res; 2009 Mar; 7(3):285-99. PubMed ID: 19276185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Membrane-anchored serine protease matriptase regulates epithelial barrier formation and permeability in the intestine.
    Buzza MS; Netzel-Arnett S; Shea-Donohue T; Zhao A; Lin CY; List K; Szabo R; Fasano A; Bugge TH; Antalis TM
    Proc Natl Acad Sci U S A; 2010 Mar; 107(9):4200-5. PubMed ID: 20142489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of HAI-2 in mice with decreased prostasin activity leads to an early-onset intestinal failure resembling congenital tufting enteropathy.
    Szabo R; Bugge TH
    PLoS One; 2018; 13(4):e0194660. PubMed ID: 29617460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Claudin-7 promotes the epithelial-mesenchymal transition in human colorectal cancer.
    Philip R; Heiler S; Mu W; Büchler MW; Zöller M; Thuma F
    Oncotarget; 2015 Feb; 6(4):2046-63. PubMed ID: 25514462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of TROP2 (TACSTD2), an EpCAM-like molecule, as a specific marker for TGF-β1-dependent human epidermal Langerhans cells.
    Eisenwort G; Jurkin J; Yasmin N; Bauer T; Gesslbauer B; Strobl H
    J Invest Dermatol; 2011 Oct; 131(10):2049-57. PubMed ID: 21677668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The protease inhibitor HAI-2, but not HAI-1, regulates matriptase activation and shedding through prostasin.
    Friis S; Sales KU; Schafer JM; Vogel LK; Kataoka H; Bugge TH
    J Biol Chem; 2014 Aug; 289(32):22319-32. PubMed ID: 24962579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cleavage of hepatocyte growth factor activator inhibitor-1 by membrane-type MMP-1 activates matriptase.
    Domoto T; Takino T; Guo L; Sato H
    Cancer Sci; 2012 Mar; 103(3):448-54. PubMed ID: 22118498
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.